What is typical presentation and time course for belimumab infusion-related depression and/or hallucinations, and how do you approach management?   

As the reported occurrence of severe depression AEs is rare (<0.5%), one can not really ascribe a 'typical' presentation to depression occurring in the context of treatment with belimumab infusions. The reasons/mechanisms underlying the consistently observed increased incidence of this AE in both...